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Background: Whether non-alcoholic fatty liver disease (NAFLD) is a risk factor for gallstones remains uncertain. Few
longitudinal or cohort studies have been used to identify this relationship. The aim of this study was to confirm the
association between NAFLD and gallstones in a longitudinal cohort of urban dwellers in China.
Methods: To elucidate the association between NAFLD and gallstones, we fitted a generalized estimating equation
(GEE) model in a large-scale longitudinal cohort over 6 years, which included 11,200 participants with at least three
regular health check-ups.
Results: A total of 498 cases of gallstones occurred during the 6-year follow-up, which resulted in a total incidence
density of 12.73 per 1000 person-years (498/39, 135.5 person-years). The GEE analyses confirmed and clarified the
association between NAFLD and gallstones (relative risk (RR) = 1.2381, 95% confidence interval (CI) = 1.003–1.528,
P = 0.047) after adjusting for other potential confounding factors, especially in females (RR = 1.707, 95% CI = 1.245–
2.341, P = 0.001).
Conclusions: NAFLD is associated with gallstones in an urban Chinese population from the middle to upper
socioeconomic strata. Moreover, this association is more strongly apparent in females than in males. Further cohort
studies must be conducted to confirm this association in the general population.
Keywords: Gallstones, Non-alcoholic fatty liver disease (NAFLD), Longitudinal cohort study, Generalized estimated
equation (GEE)Background
Gallstones are common digestive disorders that constitute
a significant health problem in Western countries [1]. In
recent years, their presence has also been increasing in
China. For persons older than 20 years, the prevalence of
gallstone disease is rapidly increasing to as high as 3.8% in
southern China and 6.1% in northern China [2]. Some
factors including ethnicity [1,3], genetic susceptibility [4],
age, gender, obesity [5], insulin resistance [6], and type 2* Correspondence: liu-yx@sdu.edu.cn
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unless otherwise stated.diabetes mellitus [7], have been reported to be risk factors
for gallstone development. However, the pathogenic mech-
anisms of gallstone formation have not been fully ascer-
tained. Further explorations of risk factors for gallstone
development are needed to aid in the early identification
and prediction of gallstones.
Non-alcoholic fatty liver disease (NAFLD) describes a
wide extent of liver conditions ranging from simple stea-
tosis to non-alcoholic steatohepatitis and cirrhosis. The
prevalence of NAFLD is reported as approximately 15%
in Asians [8]. It is not yet clear as to what role NAFLD
may play in gallstone formation. Various cross-sectional
studies have indicated that NAFLD is associated with gall-
stones [9-13]. The prevalence of gallstone disease wass is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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eral adult population in Italy [9,10]. NAFLD was found to
be an independent risk predictor for gallstone disease in
Slovakian patients with metabolic risk factors [11]. The as-
sociation between fatty liver and gallstones was also found
in the Chinese [12] and Japanese [13] populations. How-
ever, conclusions from cross-sectional studies remain in-
sufficient to confirm whether NAFLD is an independent
risk factor for gallstones. There are three potential hypoth-
eses to explain why gallstones are always accompanied by
NAFLD. (1) Given that both gallstones and NAFLD have
a high prevalence in the general population, it is likely to
be a chance co-occurrence. (2) Gallstones and NAFLD
share common risk factors [5-8], including obesity, insulin
resistance, and type 2 diabetes mellitus. (3) NAFLD is an
independent risk factor for gallstones.
Sustained efforts are presently directed at clarifying
the relationship between NAFLD and gallstones, with
the goal of identifying high-risk groups and providing
clues for exploring the pathogenic mechanisms of gall-
stone formation. Results from a large population-based
case–control study in China have shown that a history
of liver conditions, especially liver cirrhosis, is a risk fac-
tor for gallstone development [14]. However, conclusions
from such a case–control study are still not sufficient to
confirm whether NAFLD is an independent risk factor
for gallstones. Therefore, we conducted a large-scale lon-
gitudinal cohort study, based on health check-ups, in an
urban Han Chinese population from middle to upper
socioeconomic strata to further confirm the association
between NAFLD and gallstones. A simple generalized esti-
mating equation (GEE) model was first used to select po-
tential confounding factors of gallstone development, and
the multiple GEE model was further adopted to detect the
association between NAFLD and gallstones. The longitu-
dinal design allowed us to use repeated observations of
the same set of variables during the follow-up, and the
GEE model was adjusted to explore the inherent correla-
tions among the observations.
Methods
Study samples
A large-scale longitudinal cohort study was set up in 2005,
comprising urban Han Chinese from middle to upper
socioeconomic strata who attended a routine health
check-up at Centers for Health Management of Shandong
Provincial Qianfoshan Hospital and Shandong Provincial
Hospital. The geographic area served by the two hospitals
covered the city of Jinan, the capital of Shandong province
with a population of approximately 7 million. The health
check-up database contained relatively rich and educated
persons in Jinan, representing the middle to upper class
population of Shandong province. Based on the large-
scale longitudinal cohort, a sub-cohort was selected fromthose free of gallstones at baseline. A total of 11,200 par-
ticipants with at least three health checks in the 6-year
follow-up were included in the sub-cohort between 2005
and 2010 (Figure 1).
Patients’ characteristics and laboratory tests
All participants underwent a general health question-
naire, physical examination, and fasting laboratory assay.
The general health questionnaire covered smoking, alcohol
intake, sleeping quality, and physical activity. The physical
examination included height, weight, systolic blood pres-
sure, and diastolic blood pressure. The body mass index
(BMI) was calculated as weight (kg) divided by height (m)
squared. After 5 minutes of seated rest, blood pressure was
measured from the right arm of the seated participant
using an automated sphygmomanometer. Fasting labora-
tory assays included total glucose, total cholesterol, low-
density lipoprotein, high-density lipoprotein, triglycerides,
serum total protein, serum albumin, serum globulins,
blood urea nitrogen, serum creatinine, hemoglobin, mean
corpuscular hemoglobin, red blood cell distribution width,
white blood cell count, platelet distribution width, mean
platelet volume, and thrombocytocrit. This study was
approved by the Ethics Committee of the School of Pub-
lic Health, Shandong University, and written informed
consent for participation in the study was obtained from
all participants.
Definition of gallstones
Ultrasonography was used to diagnose gallstones based
on the sonographic evidence of gallstones (one or several
echogenic, distally shadowing, possibly movable struc-
tures in the gallbladder). Cholecystectomy was defined
as the absence of a gallbladder on abdominal ultrasonog-
raphy. As the individuals in our study were healthy, there
were few cases of cholecystectomy after applying exclu-
sion criteria such as fewer than three routine health
check-ups. Therefore, cholecystectomy was excluded from
our study.
Definition of non-alcoholic fatty liver disease
According to the revised definition for NAFLD by the
Chinese Hepatology Association dating from February
2006 [15], NAFLD was diagnosed by abdominal ultrason-
ography as brightness in the liver and a diffusely echogenic
change in the liver parenchyma, with other known etio-
logic factors of chronic liver disease (alcohol intake >20 g/
day, hepatitis B antigen or hepatitis C virus antibody posi-
tive, and autoimmune hepatitis) excluded.
Missing data imputation
Multiple imputations were used to account for missing
values. Since our imputation method was selected de-
pending on the pattern of missing data and the type of
Figure 1 The longitudinal cohort study sample for analysis of association between non-alcoholic fatty liver disease and gallstones.
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method was chosen according to the MI Procedure of
SAS 9.2 [16]. Data were imputed only for covariates.
Before imputation, the extent of missing data in all vari-
ables was less than 20%; in particular, less than 17% for
drinking, smoking, quality of sleep, physical activity, tri-
glycerides, high-density lipoprotein, and low-density lipo-
protein, and 10% for other variables. After imputation, all
variables had less than 10% missing observations; in par-
ticular, less than 6% for drinking, smoking, quality of sleep,
physical activity, triglycerides, high-density lipoprotein,
and low-density lipoprotein, and 1% for other variables.
Statistical analysis
Statistical descriptions are expressed as mean ± standard
deviation for continuous variables and as frequencies
for categorical variables. Summary statistics were ob-
tained for variables of interest at both baseline andfollow-up. Mean values were compared by t test for un-
equal variances. Frequencies were compared by the chi-
squared test.
As the age and gender had been confirmed as the chief
risk factors for gallstones, the association between gall-
stones and other factors were examined after adjusting
for baseline age; moreover, males and females were ana-
lyzed both together and separately. Simple GEE models
were first used to select factors associated with gall-
stones, and multiple GEE models were further adopted
to detect the association between NAFLD and gallstones
[17]. The GEE models used ‘Logit’ as the link function.
Furthermore, the GEE model was fitted to test the regres-
sion coefficient of interaction terms between gender and
NAFLD status. All statistical analyses were performed
using SAS 9.2 (SAS Institute, Cary, NC, USA). A two-
sided P value of less than 0.05 was considered to be statis-
tically significant.
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Additional file 1: Figure S1 shows the structure of the
cohort during the 6 years of follow-up. Of the 11,200
subjects fulfilling enrollment criteria (5227 males and
5973 females), a total of 498 gallstone events occurred
over the 6-year follow-up, leading to a total incidence
density of 12.73 per 1000 person-years (498/39, 135.5
person-years), with 7.1, 14.5, 16.6, 18.7, and 2.6 per 1000
person-years of follow-up in the 1st, 2nd, 3rd, 4th, and
5th year, respectively.
The distributions of potential confounding factors of
participants grouped by NAFLD status at baseline are
shown in Table 1. The baseline prevalence of NAFLD was
30.55% in males and 13.11% in females. At baseline, statis-
tically significant differences between non-NAFLD and
NAFLD groups for the listed variables were observed
except for red blood cell distribution width, platelet
distribution width, and thrombocytocrit in males, and
serum creatinine, mean corpuscular hemoglobin, and red
blood cell distribution width in females. Additional file 2:
Table S1 shows the distributions of potential confounding
factors at the baseline survey, and their distributionsTable 1 Distribution of potential confounding factors of parti
Male
Non-NAFLD NAFLD P v
Sample size 3630 1597
Age 43.14 ± 14.73 51.11 ± 13.89 <0
BMI 23.47 ± 3.08 27.38 ± 2.82 <0
SBP 120.81 ± 19.06 135.42 ± 19.49 <0
GLO 27.44 ± 4.00 28.19 ± 4.30 <0
ALB 46.35 ± 2.46 46.59 ± 2.40 <0
BUN 4.86 ± 1.26 5.32 ± 1.22 <0
CREA 77.56 ± 14.39 83.81 ± 14.09 <0
GLU 5.01 ± 0.93 5.56 ± 1.30 <0
CHOL 4.89 ± 0.94 5.32 ± 0.95 <0
TG 1.13 ± 0.87 2.06 ± 1.51 <0
HDL-C 1.38 ± 0.33 1.23 ± 0.31 <0
LDL-C 2.76 ± 0.73 3.12 ± 0.71 <0
Hemoglobin 142.43 ± 14.85 151.64 ± 13.22 <0
MCH 29.85 ± 1.93 29.98 ± 1.70 0.
RDW-SD 41.41 ± 2.58 41.49 ± 2.46 0.
WBC 6.30 ± 1.50 7.08 ± 1.57 <0
PDW 12.30 ± 1.72 12.30 ± 1.70 0.
MPV 10.41 ± 0.82 10.35 ± 0.80 0.
PCT 0.25 ± 0.08 0.25 ± 0.07 0.
The abbreviations of the variables: GD = gallstones; BMI = body mass index; SBP = sy
blood urea nitrogen; CREA = serum creatinine; GLU = total glucose; TC = Total chole
lipoprotein; Hb = Hemoglobin; MCH =mean corpuscular hemoglobin; RDW = Red bl
width; MPV =mean platelet volume; PCT = Thrombocytocri.between subjects with gallstones and subjects without
gallstones at each follow-up interval.
Table 2 shows the frequency and corresponding event
rate per 1000 person-years of gallstone events among sub-
jects with and without NAFLD. Of the 4713 individuals
who suffered NAFLD, 289 (6.1%) developed gallstones
during the follow-up years, leading to an incidence density
of 31.75 per 1000 person-years. For the individuals with-
out NAFLD, 209 of 6487 (3.2%) developed gallstones, with
the event rate decreasing to 6.96 per 1000 person-years.
When subgroup analysis was performed in males and fe-
males, the frequency of gallstones in the NAFLD group
was over 20 times higher than in the non-NAFLD group
in females, whereas in males the frequency of gallstones in
both groups was similar.
Additional file 3: Tables S2, Additional file 4: Table S3,
Additional file 5: Table S4 show the results of age-adjusted
simple GEE models in all participants, and in males and
females, respectively. In all participants, BMI, systolic
blood pressure, serum albumin, serum globulins, glucose,
and triglycerides were statistically significant (Additional
file 3: Table S2). In gender-specific analyses, BMI, systoliccipants grouped by NAFLD status at baseline
Female
alue Non-NAFLD NAFLD P value
5308 665
.001 40.65 ± 12.61 54.11 ± 13.29 <0.001
.001 22.83 ± 3.06 27.35 ± 3.23 <0.001
.001 115.94 ± 17.67 136.09 ± 21.31 <0.001
.001 27.81 ± 3.93 29.54 ± 4.41 <0.001
.001 46.02 ± 2.40 45.78 ± 2.56 0.019
.001 4.51 ± 1.16 4.92 ± 1.22 <0.001
.001 70.28 ± 10.12 70.98 ± 10.59 0.096
.001 4.90 ± 0.81 5.73 ± 1.47 <0.001
.001 4.88 ± 0.97 5.55 ± 1.04 <0.001
.001 0.99 ± 0.79 1.91 ± 1.39 <0.001
.001 1.47 ± 0.32 1.35 ± 0.32 <0.001
.001 2.69 ± 0.74 3.22 ± 0.77 <0.001
.001 134.20 ± 11.51 138.62 ± 10.96 <0.001
004 29.51 ± 2.10 29.41 ± 2.06 0.275
232 41.35 ± 2.52 41.28 ± 2.30 0.498
.001 6.14 ± 1.47 6.95 ± 1.62 <0.001
977 12.31 ± 1.72 12.16 ± 1.57 0.032
001 10.46 ± 0.81 10.32 ± 0.76 <0.001
797 0.26 ± 0.09 0.27 ± 0.06 <0.001
stolic blood pressure; GLO = serum globulins; ALB = serum albumin; BUN =
sterol; TG = triglycerides; LDL = low-density lipoprotein; HDL = high-density
ood cell distribution width; WBC = white blood cell; PDW = Platelet distribution
Table 2 Gallstone events by non-alcoholic fatty liver disease (NAFLD) status
N (%) Gallstone events (%) Person-year observation Event rate (per 1000 person-years)
All NAFLD 4713(42%) 289(6.1%) 9103.5 31.7
non-NAFLD 6487(58%) 209(3.2%) 30032 7
Male NAFLD 2982(57%) 108(3.6%) 6097 17.7
non-NAFLD 2245(43%) 166(7.4%) 12025.5 13.8
Female NAFLD 1731(29%) 181(10.5%) 3006.5 60.2
non-NAFLD 4242(71%) 43(1%) 18006.5 2.4
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triglycerides, and white blood cell count were statistically
significant for males (Additional file 4: Table S3). Serum
albumin, serum globulins, and glucose were statistically
significant for females (Additional file 5: Table S4).
Table 3 shows the summarized results of GEE analyses
regarding the association between NAFLD and gallstones
(for detailed information, see Additional file 3: Tables S2,
Additional file 4: Table S3, Additional file 5: Table S4,
Additional file 6: Table S5, Additional file 7: Table S6
and Additional file 8: Table S7). The following results were
obtained. (1) NAFLD was associated with gallstones (rela-
tive risk (RR) = 1.427, P < 0.001); after adjusting for age in
all participants (Additional file 3: Table S2), this associ-
ation was still significant (RR = 1.238, 95% confidence
interval (CI) =1.003–1.528, P = 0.047), after further adjust-
ing for other potential confounders in the multiple GEE
model (Additional file 6: Table S5). (2) When using
gender-specific analyses the association became stron-
ger in females, not only in the age-adjusted simple GEE
model (RR =1.807, 95% CI = 1.277–2.558, P = 0.001) but
also in the multiple GEE model (RR = 1.707, 95% CI =
1.245–2.341, P = 0.001) after further adjusting for other
potential confounders (Additional file 4: Tables S3 and
Additional file 7: Table S6), whereas no association was de-
tected in males (Additional file 5: Tables S4 and Additional
file 8: Table S7). Moreover, the interaction between gender
and NAFLD status was statistically significant (P = 0.016).Table 3 Results of generalized estimating equation (GEE)
analysis for non-alcoholic fatty liver disease (NAFLD) and
gallstones with their risk ratio (RR) and 95% confidence
intervals (CI)
Age-adjusted Multivariate-adjusted
RR 95% CI P value RR 95% CI P value
All 1.427 1.171-1.738 <0.001 1.238 1.003-1.528 0.047
Male 1.188 0.931-1.515 0.166 1.007 0.769-1.318 0.961
Female 1.807 1.277-2.558 0.001 1.707 1.245-2.341 0.001
The association between NAFLD and gallstones was assessed by multiple GEE
analysis with age, BMI, SBP, ALB, GLO, TG and GLU adjustment in
all participants.
The association between NAFLD and gallstones was assessed by multiple GEE
analysis with age, BMI, SBP, GLO, ALB, GLU, TG and WBC adjustment in male.
The association between NAFLD and gallstones was assessed by multiple GEE
analysis with gender, age, ALB, GLO and GLU adjustment in female.These results indicate that NAFLD was an independent
risk factor for gallstones in the female rather than the
male population.
Discussion
In this longitudinal cohort study, our findings have mainly
shown that NAFLD is an independent risk factor for gall-
stone development, especially in females. As the patho-
genic mechanisms of gallstone formation have not been
fully ascertained, accurate assessment of a high-risk popu-
lation becomes crucial to decreasing the prevalence of
gallstones. Approximately 10% of females with NAFLD
developed gallstones during the 6-year follow-up, making
this a high-risk population for gallstones.
The relevant findings of this study are as follows. (1) An
elevated incidence density of gallstones in the NAFLD
group was observed in comparison with the non-NAFLD
group. This finding is in accordance with the results of
cross-sectional studies in various populations from Italy,
Japan, and China [9-14,18]. (2) The time sequence of ad-
vancement from NAFLD to the presence of gallstones has
been confirmed, providing solid evidence that NAFLD is
an independent risk factor for gallstones in females.
Specifically, females with NAFLD are about two times as
likely as females without NAFLD to have gallstones, after
adjustments for potential confounding factors (see Table 3),
but such a trend is not observed in males. Various studies
have shown that gallstones are a female-predominant dis-
ease [19], whereas NAFLD is predominant in males [20].
However, whether males or females are more susceptible
to gallstones in a NAFLD population remains unknown.
Although a cross-sectional study showed that the asso-
ciation between NAFLD and gallstones was stronger in
males than in females [18], the time sequence between
NAFLD and gallstones was not ascertained, owing to
the disadvantageous study design. Moreover, this dis-
crepancy might also be due to differences in ethnicity.
Our present longitudinal cohort study confirms that
NAFLD is associated with gallstones in females rather
than males (see Table 3), implying a continuing such
trend in the future. Therefore, more attention should be
paid to the female population with NAFLD in compiling
clinical guidelines. Based on various studies [6,21-27], the
authors propose two hypotheses to explain the gender
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gallstones. (1) Males tend to develop an antioxidant reac-
tion through overload of uric acid while females react
more easily through glucose metabolism, which is associ-
ated with biliary cholesterol secretion and subsequent pro-
motion of cholesterol gallstone formation. (2) Estrogen
aggravates lipoapoptosis in females with NAFLD, which
results in supersaturated cholesterol of bile, further pro-
moting the formation of crystalline precipitate and ul-
timately leading to gallstone formation. However, these
hypotheses need further research on their molecular
mechanisms before they can be verified.
The advantage of the present study is that it is based
on a large-scale longitudinal cohort design, which ascer-
tains the time sequence from NAFLD to gallstones to
confirm that NAFLD is an independent risk factor for
gallstone development. Although the causal relationship
between NAFLD and gallstones could not be examined
by this longitudinal study, it has nonetheless provided
solid evidence that NAFLD is an independent risk factor
for gallstones in female subjects. However, some disad-
vantages do exist in our study. Owing to the inherent
weakness of our routine health check-up database, we
were unable to obtain information on family history and
the use of medication. Considering that the study cohort
contained only the urban population of middle to upper
socioeconomic strata in Shandong province, and that no
information on alanine aminotransferase and aspartate
aminotransferase were included, further larger validation
cohort studies are needed to confirm our results.Conclusion
NAFLD is associated with gallstones in an urban Chinese
population of middle to upper socioeconomic strata. In
gender-specific analyses, this association was strongly
confirmed in females but not in males. Further cohort
studies are required to confirm this association in the
general population.Additional files
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